Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 15Breast 15Gastrointestinal 14Thoracic 6Head & Neck 6Endocrine 6Genitourinary 4Tumor-Agnostic 3Other 2Sarcoma 1Other solid neoplasm 1Other neoplasm 1

Conditions

Neoplasms 3

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Dexmedetomidine × Tumor-Agnostic × Clear all
NCT06409104 2024-05-14

Propofol Versus Dexmedetomidine for Sedation of Cancer Patients Undergoing ERCP

National Cancer Institute, Egypt

Phase NA Completed
202 enrolled
Tumor-Agnostic

Neoplasms

NCT05636566 2022-12-05

Comparing TIVA Using Propofol or Dexmedetomidine Versus Sevoflurane During Anaesthesia of Children Undergoing Bone-Marrow Aspiration

Alexandria University

Phase 2/3 Completed
60 enrolled
Tumor-Agnostic

Neoplasms

NCT02641938 2018-01-02

Effect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury

Gangnam Severance Hospital

Phase 4 Completed
38 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡